Dr. Alexandre Jr Carre, MD

Dr. Carre practices at Day Kimball Hospital in Putnam, Connecticut, part of Day Kimball Health.

Dr. Carre's NPI, 1174658017, was assigned on February 22, 2007. Dr. Carre holds Connecticut license 032611.

Dr. Carre's primary practice is Day Kimball Hospital, at 320 Pomfret Street, Putnam, CT 06260 in Windham County. The practice phone is (860) 928-6541.

Dr. Carre's primary practice is Day Kimball Hospital in Putnam, Connecticut, part of Day Kimball Health. The medical group on file is Day Kimball Health. Dmand AI also links Dr. Carre to 1 more medical group, named with a free account. Dr. Carre's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carre practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Carre's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Carre is licensed in Connecticut.

CMS data shows 340 Medicare services from Dr. Carre across 5 procedure codes in 2024, for 57 Medicare patients. Medicare paid $23,692 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 57 Medicare patients who saw Dr. Carre in 2024. The largest group is under 65, with 40 patients. 75% of them have anxiety, and 75% have depression. 79% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carre's median patient age at 53, with 54% women.

In 2024, Dr. Carre wrote 136 Medicare Part D claims for 58 patients. 90% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $46 in total drug cost. In 2023, CMS named 72 claims across 5 drugs.

Dr. Carre accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 15 general payments to Dr. Carre from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $285.